360 related articles for article (PubMed ID: 22411804)
1. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo.
Villenave R; Thavagnanam S; Sarlang S; Parker J; Douglas I; Skibinski G; Heaney LG; McKaigue JP; Coyle PV; Shields MD; Power UF
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5040-5. PubMed ID: 22411804
[TBL] [Abstract][Full Text] [Related]
2. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium.
Guo-Parke H; Canning P; Douglas I; Villenave R; Heaney LG; Coyle PV; Lyons JD; Shields MD; Power UF
Am J Respir Crit Care Med; 2013 Oct; 188(7):842-51. PubMed ID: 23952745
[TBL] [Abstract][Full Text] [Related]
3. Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
Villenave R; Broadbent L; Douglas I; Lyons JD; Coyle PV; Teng MN; Tripp RA; Heaney LG; Shields MD; Power UF
J Virol; 2015 Dec; 89(24):12309-18. PubMed ID: 26423940
[TBL] [Abstract][Full Text] [Related]
4. Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells.
Villenave R; O'Donoghue D; Thavagnanam S; Touzelet O; Skibinski G; Heaney LG; McKaigue JP; Coyle PV; Shields MD; Power UF
Virol J; 2011 Jan; 8():43. PubMed ID: 21272337
[TBL] [Abstract][Full Text] [Related]
5. The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins.
Touzelet O; Broadbent L; Armstrong SD; Aljabr W; Cloutman-Green E; Power UF; Hiscox JA
Mol Cell Proteomics; 2020 May; 19(5):793-807. PubMed ID: 32075873
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus interaction with human airway epithelium.
Villenave R; Shields MD; Power UF
Trends Microbiol; 2013 May; 21(5):238-44. PubMed ID: 23523320
[TBL] [Abstract][Full Text] [Related]
7. Roflumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells.
Mata M; Martinez I; Melero JA; Tenor H; Cortijo J
PLoS One; 2013; 8(7):e69670. PubMed ID: 23936072
[TBL] [Abstract][Full Text] [Related]
8. Primary airway epithelial cultures from children are highly permissive to respiratory syncytial virus infection.
Fonceca AM; Flanagan BF; Trinick R; Smyth RL; McNamara PS
Thorax; 2012 Jan; 67(1):42-8. PubMed ID: 21865207
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation.
Persson BD; Jaffe AB; Fearns R; Danahay H
PLoS One; 2014; 9(7):e102368. PubMed ID: 25033192
[TBL] [Abstract][Full Text] [Related]
10. Human airway epithelial cell cultures for modeling respiratory syncytial virus infection.
Pickles RJ
Curr Top Microbiol Immunol; 2013; 372():371-87. PubMed ID: 24362700
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Reprogramming of Nasal Airway Epithelial Cells Following Infant Respiratory Syncytial Virus Infection.
Connelly AR; Jeong BM; Coden ME; Cao JY; Chirkova T; Rosas-Salazar C; Cephus JY; Anderson LJ; Newcomb DC; Hartert TV; Berdnikovs S
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696488
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-Airway Epithelial Interactions Result in Increased Epithelial Damage and Viral Clearance during Respiratory Syncytial Virus Infection.
Deng Y; Herbert JA; Robinson E; Ren L; Smyth RL; Smith CM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295918
[TBL] [Abstract][Full Text] [Related]
13. miRNA-34b/c regulates mucus secretion in RSV-infected airway epithelial cells by targeting FGFR1.
Li W; Du X; Yang Y; Yuan L; Yang M; Qin L; Wang L; Zhou K; Xiang Y; Qu X; Liu H; Qin X; Xiao G; Liu C
J Cell Mol Med; 2021 Nov; 25(22):10565-10574. PubMed ID: 34636482
[TBL] [Abstract][Full Text] [Related]
14. Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells.
Villenave R; Touzelet O; Thavagnanam S; Sarlang S; Parker J; Skibinski G; Heaney LG; McKaigue JP; Coyle PV; Shields MD; Power UF
J Virol; 2010 Nov; 84(22):11718-28. PubMed ID: 20810726
[TBL] [Abstract][Full Text] [Related]
15. Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response.
Lay MK; González PA; León MA; Céspedes PF; Bueno SM; Riedel CA; Kalergis AM
Microbes Infect; 2013 Mar; 15(3):230-42. PubMed ID: 23246463
[TBL] [Abstract][Full Text] [Related]
16. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
Broadbent L; Parke HG; Ferguson LJ; Millar A; Shields MD; Detalle L; Power UF
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767728
[TBL] [Abstract][Full Text] [Related]
17. Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
Kinder JT; Moncman CL; Barrett C; Jin H; Kallewaard N; Dutch RE
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759319
[TBL] [Abstract][Full Text] [Related]
18. RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.
Liesman RM; Buchholz UJ; Luongo CL; Yang L; Proia AD; DeVincenzo JP; Collins PL; Pickles RJ
J Clin Invest; 2014 May; 124(5):2219-33. PubMed ID: 24713657
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Modeling of RSV Infection and Cytopathogenesis in Well-Differentiated Human Primary Airway Epithelial Cells (WD-PAECs).
Broadbent L; Villenave R; Guo-Parke H; Douglas I; Shields MD; Power UF
Methods Mol Biol; 2016; 1442():119-39. PubMed ID: 27464691
[TBL] [Abstract][Full Text] [Related]
20. Central Role of the NF-κB Pathway in the
Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Wakamiya M; Garofalo RP; Brasier AR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
